title: Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis.
abstract: Dermal delivery of fluconazole (FLZ) is still a major limitation due to problems relating to control drug release and achieving therapeutic efficacy. Recently, solid lipid nanoparticles (SLNs) were explored for their potential of topical delivery, possible skin compartments targeting and controlled release in the skin strata. The retention and accumulation of drug in skin is affected by composition of SLNs. Hence, the aim of this study was to develop FLZ nanoparticles consisted of various lipid cores in order to optimize the drug retention in skin. SLNs were prepared by solvent diffusion method and characterized for various in vitro and in vivo parameters. The results indicate that the SLNs composed of compritol 888 ATO (CA) have highest drug encapsulation efficiency (75.7 ± 4.94%) with lower particle size (178.9 ± 3.8 nm). The in vitro release and skin permeation data suggest that drug release followed sustained fashion over 24 h. The antifungal activity shows that SLNs made up of CA lipid could noticeably improve the dermal localization. In conclusion, CA lipid based SLNs are represents a promising carrier means for the topical treatment of skin fungal infection as an alternative to the systemic delivery of FLZ.
authors.affiliation: Drug Delivery Research Laboratory, Department of Pharmaceutical sciences, Dr. H. S. Gour Viswavidyalaya, Sagar-470003, MP, India.
authors.forename: Madhu
authors.initials: M
authors.lastname: Gupta
authors.forename: Shailja
authors.initials: S
authors.lastname: Tiwari
authors.forename: Suresh P
authors.initials: SP
authors.lastname: Vyas
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000378:metabolism; D002179:Candidiasis, Cutaneous / Q000188:drug therapy* / Q000378:metabolism; D016503:Drug Delivery Systems / Q000379:methods*; D015725:Fluconazole / Q000008:administration & dosage* / Q000737:chemistry / Q000378:metabolism; D008055:Lipids / Q000008:administration & dosage* / Q000737:chemistry; D008297:Male; D053758:Nanoparticles / Q000008:administration & dosage* / Q000737:chemistry; D009924:Organ Culture Techniques; D011817:Rabbits; D051381:Rats; D054772:Rats, Hairless; D017207:Rats, Sprague-Dawley
chemical_list: D000935:Antifungal Agents; D008055:Lipids; D015725:Fluconazole